[Angiotensin converting enzyme inhibitors in prevention and treatment of vascular complications of diabetes].
作者信息
Ametov A S, Demidova T Iu, Galieva O R
出版信息
Kardiologiia. 2005;45(11):109-12.
PMID:16353074
Abstract
摘要
相似文献
1
[Angiotensin converting enzyme inhibitors in prevention and treatment of vascular complications of diabetes].
Kardiologiia. 2005;45(11):109-12.
2
Summaries for patients. The cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for patients with diabetes.
Ann Intern Med. 2005 Jul 19;143(2):I21. doi: 10.7326/0003-4819-143-2-200507190-00002.
3
Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.
Arch Intern Med. 2003 May 12;163(9):1025-9. doi: 10.1001/archinte.163.9.1025.
4
[Angiotensin converting enzyme inhibitors in arterial hypertension].
Rev Esp Cardiol. 1999;52 Suppl 3:73-8.
5
Kidney disease in diabetology: lessons from 2008.
Nephrol Dial Transplant. 2009 Feb;24(2):396-9. doi: 10.1093/ndt/gfn694.
6
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?
Diabetologia. 1991 Feb;34(2):137-8.
7
Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
Scott Med J. 1997 Aug;42(4):99-104. doi: 10.1177/003693309704200401.
8
Reduction of body iron stores and the prevention of type 2 diabetes.
Am J Med. 2007 Jan;120(1):e13; author reply e15. doi: 10.1016/j.amjmed.2005.11.024.
9
Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.
Expert Rev Cardiovasc Ther. 2013 Jun;11(6):719-28. doi: 10.1586/erc.13.36.
10
Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.
Thromb Haemost. 2005 Jan;93(1):8-16. doi: 10.1160/TH04-07-0453.
Zotero 插件